Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALX Oncology Holdings

0.5100
-0.0203-3.83%
Post-market: 0.51000.00000.00%18:42 EDT
Volume:616.68K
Turnover:309.18K
Market Cap:27.23M
PE:-0.20
High:0.5399
Open:0.5275
Low:0.4902
Close:0.5303
Loading ...

ALX Oncology Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
24 Jan

ALX Oncology Shares Drop 15% Following Positive Phase 2

GuruFocus.com
·
24 Jan

BRIEF-Alx Oncology Presents Positive Updated Data From Aspen-06 Phase 2 Trial

Reuters
·
23 Jan

ALX Oncology Presents Positive Updated Data From Aspen-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients With Her2-Positive Gastric Cancer

THOMSON REUTERS
·
23 Jan

ALX Oncology Reports Inducement Grant as Permitted by the Nasdaq Listing Rules

THOMSON REUTERS
·
23 Jan

ALX Oncology Names New CFO; Shares Rise

MT Newswires Live
·
23 Jan

ALX Oncology Announces Further Additions to Leadership Team and Board of Directors, Appointing Harish Shantharam as Chief Financial Officer and Adding Barbara Klencke and Chris Takimoto to Board of Directors

THOMSON REUTERS
·
22 Jan

Press Release: ALX Oncology Announces Further Additions to Leadership Team and Board of Directors, Appointing Harish Shantharam as Chief Financial Officer and Adding Barbara Klencke and Chris Takimoto to Board of Directors

Dow Jones
·
22 Jan

3 US Penny Stocks With Market Caps Under $100M To Watch

Simply Wall St.
·
09 Jan

ALX Oncology Shares Fall After Downgrade From Jefferies

MT Newswires Live
·
20 Dec 2024

Alx Oncology shares down in pre-market as Jefferies downgrades stock to 'hold'

Investing.com
·
19 Dec 2024

Jefferies Downgrades ALX Oncology to Hold From Buy, Cuts Price Target to $2 From $12

MT Newswires Live
·
19 Dec 2024

ALX Oncology Holdings Inc : Jefferies Cuts to Hold From Buy; Cuts Target Price to $2 From $12

THOMSON REUTERS
·
19 Dec 2024

ALX Oncology Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Dec 2024

ALX Oncology Holdings (ALXO) Gets a Hold from LifeSci Capital

TIPRANKS
·
18 Dec 2024

ALX Oncology to host virtual event to discuss Phase 1b/2 evorpacept data

TIPRANKS
·
12 Dec 2024

ALX Oncology Holdings Inc - Combination Therapy Well Tolerated With Manageable Safety Profile

THOMSON REUTERS
·
10 Dec 2024

ALX Oncology Announces New Data Demonstrating Evorpacept in Combination With Zanidatamab Generates Promising Antitumor Activity in Advanced Breast Cancer

THOMSON REUTERS
·
10 Dec 2024

3 US Penny Stocks With Market Caps Over $30M To Consider

Simply Wall St.
·
27 Nov 2024

ALX Oncology Holdings (ALXO) Loses -27.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks
·
21 Nov 2024